Breathing-Related Sleep Disorder

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

P
PhilipsNetherlands - Amsterdam
1 program
AVAPS-AE Non-invasive ventilation therapyN/A1 trial
Active Trials
NCT02446769Terminated18Est. May 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PhilipsAVAPS-AE Non-invasive ventilation therapy

Clinical Trials (1)

Total enrollment: 18 patients across 1 trials

NCT02446769PhilipsAVAPS-AE Non-invasive ventilation therapy

A Pilot Study to Assess the Effects of a Novel Application of Averaged Volume Assured Pressure Support Ventilation (AVAPS-AE) Therapy on Re-hospitalization in Patients With Sleep-Disordered Breathing With Co-morbid COPD

Start: Oct 2017Est. completion: May 201818 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space